David Munoz

David Munoz is a dedicated Therapeutic Specialist at Crinetics Pharmaceuticals since June 2025, focusing on addressing unmet needs in the Endocrine space for rare diseases. Prior to this role, David served as a Specialty Account Manager at Horizon from November 2020 to June 2025, where responsibilities included expanding the understanding of Thyroid Eye Disease and promoting the treatment Tepezza. Additionally, David's experience includes positions as a Benlysta Senior Account Specialist at GSK and as an Acthar Specialist at Mallinckrodt Pharmaceuticals, where strategic initiatives advanced patient treatment options. David began a career in pharmaceuticals with Otsuka Pharmaceutical Companies, managing hospital accounts focused on Hyponatremia treatment. David holds a Bachelor's degree in Business Administration and Management from Biola University.